A novel lncRNA-hidden polypeptide regulates malignant phenotypes and pemetrexed sensitivity in A549 pulmonary adenocarcinoma cells - Han, Xiaobing; Chen, Liangxin; Sun, Peng; Wang, Xiuqing; Zhao, Qian; Liao, Lingfeng; Lou, Dejin; Zhou, Nan; Wang, Yujun (Amino acids, 2024)
Keywords: A549 Cells; Adenocarcinoma; Adenocarcinoma - drug therapy; Adenocarcinoma - genetics; Adenocarcinoma - metabolism; Analytical Chemistry; Anticancer properties; antineoplastic agents; Antineoplastic drugs; bioactive properties; Biochemical Engineering; Biochemistry; Bioinformatics; Biological activity; Biomedical and Life Sciences; Cancer; Cell growth; Cell Line, Tumor; Cell migration; Cell Proliferation; Cell viability; DNA biosynthesis; DNA replication; fluorescent antibody technique; Gene Expression Regulation, Neoplastic; Humans; Immunofluorescence; Immunoprecipitation; Life Sciences; LINC00954-ORF; lncRNA-hidden polypeptides; Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; lungs; Mass spectrometry; Mass spectroscopy; Neurobiology; Next-generation sequencing; Non-coding RNA; NSCLC; Open reading frames; Original; Original Article; PEM resistance; Pemetrexed - metabolism; Pemetrexed - pharmacology; Peptides - metabolism; Phenotype; Phenotypes; Polypeptides; precipitin tests; protein synthesis; Proteins; Proteomics; Ribonucleic acid; RNA; RNA processing; RNA transport; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Sensitivity enhancement; Short ORFs; Tumors; Western blotting; lncRNA-hidden polypeptides; Short ORFs; NSCLC; LINC00954-ORF; PEM resistance